- Report
- April 2023
- 71 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- April 2023
- 89 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- April 2022
- 91 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- June 2023
- 114 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2021
- 302 Pages
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- November 2024
- 260 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- November 2023
- 248 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- March 2023
- 374 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- March 2022
- 175 Pages
Global
From €2271EUR$2,496USD£1,929GBP
€3245EUR$3,565USD£2,756GBP
- Report
- March 2021
- 206 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- February 2012
- 216 Pages
- Book
- January 2012
- 464 Pages
- Book
- January 2020
- 504 Pages
- Book
- January 2020
- 504 Pages

The Transdermal and Transmucosal Drug Delivery market is a sector of the pharmaceutical industry that focuses on the development and manufacture of drugs that are administered through the skin or mucous membranes. These drugs are designed to be absorbed directly into the bloodstream, bypassing the digestive system. This method of drug delivery is advantageous as it can provide a more consistent and sustained release of the drug, as well as reducing the risk of side effects.
Transdermal and Transmucosal Drug Delivery products are used to treat a variety of conditions, including pain, allergies, and hormone replacement therapy. Companies in this market are developing innovative products to improve the efficacy and safety of drug delivery. Examples of such products include patches, gels, and sprays.
Notable companies in the Transdermal and Transmucosal Drug Delivery market include Mylan, Novartis, and GlaxoSmithKline. Show Less Read more